View Clinical Trial (Medical Research Study)
Enabling Sleep Apnea Patient-Centered Care Via an Internet Intervention - NCT00662623-92103(Clinical Trial 216436)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
San Diego |
|
State:
|
|
CA |
| Zip Code: |
|
92103 |
| Conditions: |
|
Sleep Apnea Syndromes |
| Purpose: |
|
The purpose of this study is to examine the effect of different methods of providing
education about sleep apnea and continuous positive airway pressure therapy (CPAP) use and
how that education might help to improve health outcomes and the amount of time CPAP is
used.
|
| Study summary: |
|
Poor treatment adherence with CPAP therapy is well-documented. Set against a backdrop of
telemedicine applications that have grown as fast in unsubstantiated claims and assumptions
of patient satisfaction, diagnostic accuracy, clinical efficacy, and cost-effectiveness as
they have in technological sophistication and capabilities, the evaluative aspect of this
proposal is designed as as a randomized, controlled clinical trial—Usual Care patients
(control) versus i-PAP patients (intervention). An important empirical-methodological
advantage of the project is the objective measurement of CPAP adherence, which is measured
by internal microprocessor as the "amount of time CPAP is used at the prescribed pressure."
This objective measurement allows feedback of treatment adherence and efficacy to both
patient and provider, and the i-PAP intervention was designed around this central feature. |
| Criteria: |
|
Inclusion Criteria:
- age > 18 years
- confirmed diagnosis of OSA
- being newly prescribed CPAP therapy
- having chronic symptoms as noted on screening symptom checklist
- fluency in English
Exclusion Criteria:
- cognitive impairment sufficient to cause inability to complete the protocol (MMSE <
24/30)
- residence in a geographical area outside of San Diego County
- fatal comorbidity (life expectancy less than 6 months as indicated by treating
physician)
- significant documented substance/chemical abuse or other participant
circumstances that, in the opinion of a consensus of study team, would interfere with
the safety of a prospective participant or their need for treatment |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
July 2, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|